Wednesday, Oragenics Inc. (NYSE:OGEN) announced the completion of its spray-dried formulation and filling in the nasal device for its lead candidate, ONP-002, for concussion. Oragenics is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback